Skip to main content
Premium Trial:

Request an Annual Quote

Biomax Informatics, Boehringer Ingelheim, Invitrogen, Compendia Bioscience

Premium
Boehringer Ingelheim GmbH Licenses Biomax’s BioRS Integration System
 
Biomax Informatics, a developer of customized bioinformatics solutions, has licensed its BioRS Integration and Retrieval system to Boehringer Ingelheim. Boehringer Ingelheim plans to use the BioRS system to integrate data on a platform that provides unified access to public and proprietary data sources in its global pharmaceutical R&D environment.
 
The BioRS Integration and Retrieval System is designed to retrieve biological data from multiple public and proprietary databases simultaneously using web interfaces, according to the company. Flat-file and relational databases such as Oracle and MySQL, the company said, can be integrated into the system via a web or command-line interface and standardized data formats based on Extensible Markup Language (XML).
 

 
Invitrogen Launches New STEMPRO EZChek to Simplify Cell Monitoring
 
Invitrogen, which offers tools for stem cells research and various life sciences production and diagnostics, has launched a new kit for researchers to monitor the state of human embryonic stem cells (hESCs). The STEMPRO EZChek Multiplex PCR Kit allows scientists to monitor hESCs with one reaction.
 
The STEMPRO EZChek Kit allows for the analysis of four early differentiation markers using a sample and a single-tube reaction.
 

 
Compendia Bioscience Receives $2.4M SBIR Award
 
Compendia Bioscience has received a $2.4 million SBIR Fast Track Award from the National Cancer Institute to support a project entitled, “Development of Oncomine Professional as a Platform for Biopharmaceutical Research and Development”.
 
“We are thrilled with this award from the NCI and are looking forward to executing the project, which we expect will lead to increased applicability of Oncomine Professional to drug discovery and development.” said company founder and CEO Dan Rhodes, in a statement.
 

Compendia was founded in 2006 to extend Oncomine to the commercial sector.

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.